{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:56:25Z","timestamp":1781560585259,"version":"3.54.5"},"reference-count":164,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.jtauto.2020.100039","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T20:12:20Z","timestamp":1580155940000},"page":"100039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Immune-mediated genesis of multiple sclerosis"],"prefix":"10.1016","volume":"3","author":[{"suffix":"MD","given":"Salvatore","family":"Cavallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2020.100039_bib1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2020.100039_bib2","unstructured":"Alastair Compston Ian McDonald John Noseworthy Hans Lassmann David Miller Kenneth Smith Hartmut Wekerle Christian Confavreux. McAlpine\u2019s Multiple Sclerosis. Imprint: Churchill Livingstone."},{"issue":"3","key":"10.1016\/j.jtauto.2020.100039_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Wallin","year":"2019","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jtauto.2020.100039_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/135245859800400301","article-title":"Neuropathology in multiple sclerosis: new concepts","volume":"4","author":"Lassmann","year":"1998","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2020.100039_bib5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"M1","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2020.100039_bib6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/aje\/kwk118","article-title":"HLA-DR15 haplotype and multiple sclerosis: a HuGE review","volume":"165","author":"Schmidt","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jtauto.2020.100039_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003926","article-title":"Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects","volume":"9","author":"Patsopoulos","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jtauto.2020.100039_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.autrev.2011.03.003","article-title":"Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies","volume":"10","author":"Zhang","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2020.100039_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archneur.56.5.555","article-title":"HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews","volume":"56","author":"Kwon","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jtauto.2020.100039_bib10","first-page":"410","article-title":"Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel","volume":"5","author":"Karni","year":"1999","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2020.100039_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033972","article-title":"HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia","volume":"7","author":"Cocco","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jtauto.2020.100039_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059790","article-title":"Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population","volume":"8","author":"Cocco","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jtauto.2020.100039_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/380997","article-title":"Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans","volume":"74","author":"Oksenberg","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jtauto.2020.100039_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095367","article-title":"Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients","volume":"9","author":"Yoshimura","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jtauto.2020.100039_bib15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/1352458508097818","article-title":"Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis","volume":"14","author":"Matsuoka","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2020.100039_bib16","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/WNL.55.6.842","article-title":"The increasing incidence and prevalence of MS in a Sardinian province","volume":"55","author":"Granieri","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2020.100039_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.0b013e31829bfe2f","article-title":"Genetic risk variants in African Americans with multiple sclerosis","volume":"81","author":"Isobe","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2020.100039_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1212\/01.WNL.0000149765.71212.0A","article-title":"The HLA locus and multiple sclerosis in Sicily","volume":"64","author":"Brassat","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2020.100039_bib19","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/hmg\/ddl223","article-title":"Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis","volume":"15","author":"Barcellos","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jtauto.2020.100039_bib20","first-page":"993","article-title":"HLA-DRB1* allele-associated genetic susceptibility and protection against multiple sclerosis in Brazilian patients","volume":"2","author":"Kaimen-Maciel","year":"2009","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jtauto.2020.100039_bib21","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1371\/journal.pgen.0030150","article-title":"The inheritance of resistance alleles in multiple sclerosis","volume":"3","author":"Ramagopalan","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jtauto.2020.100039_bib22","article-title":"HLA-DRB1* allele frequencies in pediatric, adolescent and adult-onset multiple sclerosis patients, in a hellenic sample. Evidence for new and established associations","volume":"1","author":"Anagnostouli","year":"2014","journal-title":"J\u00a0Mult Scler"},{"key":"10.1016\/j.jtauto.2020.100039_bib23","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1371\/journal.pone.0000664","article-title":"HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis","volume":"2","author":"Brynedal","year":"2007","journal-title":"PloS One"},{"key":"10.1016\/j.jtauto.2020.100039_bib24","unstructured":"Paola Cruz-Tapias, John Castiblanco, and Juan-Manuel Anaya. Major histocompatibility complex: antigen processing and presentation. Autoimmunity: from Bench to Bedside, (Chapter 10). El Rosario University Press."},{"issue":"1","key":"10.1016\/j.jtauto.2020.100039_bib25","first-page":"S31","article-title":"The two-signal model of t-cell activation after 30 years","volume":"73","author":"Bernard","year":"2002"},{"issue":"7591","key":"10.1016\/j.jtauto.2020.100039_bib26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares1","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jtauto.2020.100039_bib27","series-title":"Chapter 3 - Animal Models of Multiple Sclerosis","first-page":"37","article-title":"Neuroinflammation","author":"Sato","year":"2018"},{"issue":"9","key":"10.1016\/j.jtauto.2020.100039_bib28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ni1507","article-title":"Multiple sclerosis: a complicated picture of autoimmunity","volume":"8","author":"McFarland","year":"2007","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2020.100039_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1191\/135248506ms1304rr","article-title":"J\u00a0W Prineas The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion","volume":"12","author":"Barnett","year":"2006","journal-title":"Mult. Scler."},{"issue":"Suppl I","key":"10.1016\/j.jtauto.2020.100039_bib30","doi-asserted-by":"crossref","first-page":"I121","DOI":"10.1136\/ard.58.2008.i121","article-title":"The role of TNFa and lymphotoxin in demyelinating disease","volume":"58","author":"Lock","year":"1999","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jtauto.2020.100039_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T\u00a0cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2020.100039_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410340313","article-title":"The T-cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity restricting elements, and T-cell receptor usage","volume":"34","author":"Joshi","year":"1993","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jtauto.2020.100039_bib33","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/BF00968703","article-title":"Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review","volume":"19","author":"Tuohy","year":"1994","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jtauto.2020.100039_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0165-5728(99)00004-1","article-title":"Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat","volume":"95","author":"Weerth","year":"1999","journal-title":"J.\u00a0Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jtauto.2020.100039_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.autrev.2009.08.002","article-title":"The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis","volume":"9","author":"N1","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2020.100039_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-2776(08)00404-5","article-title":"B\u00a0cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases","volume":"98","author":"Katherine","year":"2008","journal-title":"Adv. Immunol."},{"issue":"Issue 4","key":"10.1016\/j.jtauto.2020.100039_bib37","first-page":"1089","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jtauto.2020.100039_bib38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"B1","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jtauto.2020.100039_bib39","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2","article-title":"B\u00a0cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide","volume":"29","author":"Lyons1","year":"1999","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.jtauto.2020.100039_bib40","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jtauto.2020.100039_bib41","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.410370404","article-title":"The adhesion molecule and cytokine profile of multiple sclerosis lesions","volume":"37","author":"Cannella","year":"1995","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.jtauto.2020.100039_bib42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0167-5699(97)01080-3","article-title":"Production of cytokines by human B cells in health and disease","volume":"18","author":"Pistoia","year":"1997","journal-title":"Immunol. Today"},{"issue":"3","key":"10.1016\/j.jtauto.2020.100039_bib43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI115102","article-title":"Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions","volume":"87","author":"Selmaj","year":"1991","journal-title":"J.\u00a0Clin. Invest."},{"issue":"6","key":"10.1016\/j.jtauto.2020.100039_bib44","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.172.6.3422","article-title":"Distinct profiles of human B cell effector cytokines: a role in immune regulation?","volume":"172","author":"Duddy","year":"2004","journal-title":"J.\u00a0Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jtauto.2020.100039_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness","volume":"180","author":"Link","year":"2006","journal-title":"J.\u00a0Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jtauto.2020.100039_bib46","first-page":"375","article-title":"De los Milagros Bassani Molinas M Oligoclonal bands and antibody responses in multiple sclerosis","volume":"249","author":"Correale","year":"2002","journal-title":"J.\u00a0Neurol."},{"issue":"2","key":"10.1016\/j.jtauto.2020.100039_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/5532","article-title":"Identification of autoantibodies associated with myelin damage in multiple sclerosis","volume":"5","author":"Genain","year":"1999","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.jtauto.2020.100039_bib48","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4049\/jimmunol.175.3.1974","article-title":"Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein","volume":"175","author":"O\u2019Connor","year":"2005","journal-title":"J.\u00a0Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2020.100039_bib49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0022-510X(93)90221-J","article-title":"Catz I Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue","volume":"115","author":"Warren","year":"1993","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jtauto.2020.100039_bib50","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1084\/jem.20071053","article-title":"Neurofascin as a novel target for autoantibody-mediated axonal injury","volume":"204","author":"Mathey","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"issue":"1\u20132","key":"10.1016\/j.jtauto.2020.100039_bib51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-5728(02)00434-4","article-title":"Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis","volume":"135","author":"Kennel De March","year":"2003","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2020.100039_bib52","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.0105-2896.2005.00240.x","article-title":"Multiple sclerosis","volume":"204","author":"Hafler","year":"2005","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.jtauto.2020.100039_bib53","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/eji.200425291","article-title":"Commentary: sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire","volume":"34","author":"Mathey","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.jtauto.2020.100039_bib54","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"issue":"5","key":"10.1016\/j.jtauto.2020.100039_bib55","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000284600.80782.d5","article-title":"Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders","volume":"70","author":"Banwell","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jtauto.2020.100039_bib56","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1371\/journal.pmed.0040133","article-title":"Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica","volume":"4","author":"Paul","year":"2007","journal-title":"PLoS Med."},{"issue":"Pt 5","key":"10.1016\/j.jtauto.2020.100039_bib57","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jtauto.2020.100039_bib58","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jtauto.2020.100039_bib59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","article-title":"Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain","volume":"17","author":"Nielsen","year":"1997","journal-title":"J.\u00a0Neurosci."},{"issue":"2","key":"10.1016\/j.jtauto.2020.100039_bib60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0972-2327.64622","article-title":"The role of infections in the pathogenesis and course of multiple sclerosis","volume":"13","author":"Pawate","year":"2010","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.jtauto.2020.100039_bib61","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ncl.2008.03.007","article-title":"Progressive multifocal leukoencephalopathy","volume":"26","author":"Weber","year":"2008","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jtauto.2020.100039_bib62","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2015.00520","article-title":"Infection as an environmental trigger of multiple sclerosis disease exacerbation","volume":"6","author":"Steelman","year":"2015","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.jtauto.2020.100039_bib63","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2174\/187152712801661220","article-title":"Viruses and multiple sclerosis","volume":"11","author":"Oskari Virtanen","year":"2012","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.jtauto.2020.100039_bib64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbadis.2010.06.012","article-title":"Viral triggers of multiple sclerosis","volume":"1812","author":"Kakalacheva","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jtauto.2020.100039_bib65","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","article-title":"Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein","volume":"80","author":"Wucherpfennig","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jtauto.2020.100039_bib66","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3181\/00379727-111-27855","article-title":"Measles antibodies in multiple sclerosis","volume":"111","author":"Adams","year":"1962","journal-title":"Proc Soc Exp Biol Med"},{"issue":"4","key":"10.1016\/j.jtauto.2020.100039_bib67","first-page":"369","article-title":"Measles virus infection and multiple sclerosis: serological studies","volume":"213","author":"Cendrowski","year":"1976","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jtauto.2020.100039_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/jnnp.36.1.57","article-title":"Serum measles antibodies in multiple sclerosis","volume":"36","author":"Cendrowski","year":"1973","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"issue":"10","key":"10.1016\/j.jtauto.2020.100039_bib69","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1212\/WNL.20.10.1039","article-title":"Measles antibodies in patients with multiple sclerosis and with other neurological and nonneurological diseases","volume":"20","author":"Adams","year":"1970","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jtauto.2020.100039_bib70","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1600-0404.1976.tb04366.x","article-title":"A\u00a0longitudinal study on antibodies to measles and rubella viruses in patients with multiple sclerosis. A preliminary report","volume":"54","author":"Reunanen","year":"1976","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jtauto.2020.100039_bib71","doi-asserted-by":"crossref","unstructured":"Paul Brown, Francoise Cathala1, D. Carleton Gajdusek, Clarence J. Gibbs, Jr.Measles antibodies in the cerebrospinal fluid of patients with multiple sclerosis. PSEBM (Proc. Soc. Exp. Biol. Med.), Volume: 137 issue: 3, page(s): 956-961.","DOI":"10.3181\/00379727-137-35704"},{"issue":"4","key":"10.1016\/j.jtauto.2020.100039_bib72","article-title":"Measles virus antibodies in multiple sclerosis comparison of antibody titers in cerebrospinal fluid and serum","volume":"30","author":"Erling Norrby","year":"1974","journal-title":"Arch. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jtauto.2020.100039_bib73","article-title":"Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome","volume":"247","author":"Ahlgren","year":"2012","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2020.100039_bib74","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jtauto.2020.100039_bib75","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archneur.64.1.72","article-title":"Multiple sclerosis after infectious mononucleosis","volume":"64","author":"Nielsen","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jtauto.2020.100039_bib76","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.jtauto.2020.100039_bib77","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","article-title":"An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study","volume":"62","author":"Sundstrom","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2020.100039_bib78","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","article-title":"Temporal relationship between elevation of Epstein Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"Levin","year":"2005","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.jtauto.2020.100039_bib79","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","article-title":"Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up","volume":"63","author":"DeLorenze","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jtauto.2020.100039_bib80","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00001648-200003000-00023","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"11","author":"Ascherio","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.jtauto.2020.100039_bib81","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1001\/jama.291.15.1875","article-title":"Epstein-Barr virus in pediatric multiple sclerosis","volume":"291","author":"Alotaibi","year":"2004","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.jtauto.2020.100039_bib82","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1212\/01.wnl.0000247665.94088.8d","article-title":"High seroprevalence of Epstein-Barr virus in children with multiple sclerosis","volume":"67","author":"Pohl","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2020.100039_bib83","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jtauto.2020.100039_bib84","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein\u2013Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"J.\u00a0Am. Med. Assoc. : J. Am. Med. Assoc."},{"key":"10.1016\/j.jtauto.2020.100039_bib85","article-title":"Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility a multiethnic study","volume":"26","author":"Langer-Gould","year":"2017","journal-title":"Neurology September"},{"issue":"6","key":"10.1016\/j.jtauto.2020.100039_bib86","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the epstein-barr virus and risk of multiple sclerosis","volume":"67","author":"Levin","year":"2010","journal-title":"Ann. Neurol."},{"issue":"Issue 4","key":"10.1016\/j.jtauto.2020.100039_bib87","article-title":"Systematic review and meta-analysis of the sero-epidemiological association between Epstein barr virusand multiple sclerosis","volume":"8","author":"Almohmeed1","year":"2013","journal-title":"PLOS one April"},{"key":"10.1016\/j.jtauto.2020.100039_bib88","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1212\/WNL.39.6.825","article-title":"A\u00a0case\u2013control study of multiple sclerosis","volume":"39","author":"Operskalski","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2020.100039_bib89","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000110248","article-title":"Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis","volume":"10","author":"Lindberg","year":"1991","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jtauto.2020.100039_bib90","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/brain\/awn108","article-title":"Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis","volume":"131","author":"Jilek","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jtauto.2020.100039_bib91","first-page":"7","article-title":"Possible role of human herpesvirus 6 as a trigger of autoimmune disease","author":"Broccolo","year":"2013","journal-title":"The ScientificWorld Journal"},{"key":"10.1016\/j.jtauto.2020.100039_bib92","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1073\/pnas.92.16.7440","article-title":"Plaque-associated expression of human herpes virus 6 in multiple sclerosis","volume":"92","author":"Challoner","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.jtauto.2020.100039_bib93","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nm1297-1394","article-title":"Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response toHHV-6 early antigen and detection of serumHHV-6 DNA","volume":"3","author":"Soldan","year":"1997","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.jtauto.2020.100039_bib94","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/135245859900500509","article-title":"The association of the human herpesvirus-6 and MS","volume":"5","author":"Friedman","year":"1999","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.jtauto.2020.100039_bib95","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jmv.10258","article-title":"Correlation between HHV-6 reactivation and multiple sclerosis disease activity","volume":"69","author":"Chapenko","year":"2003","journal-title":"J.\u00a0Med. Virol."},{"issue":"10","key":"10.1016\/j.jtauto.2020.100039_bib96","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/archneur.61.10.1523","article-title":"Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection","volume":"61","author":"Alvarez-Lafuente","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jtauto.2020.100039_bib97","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/1352458511428081","article-title":"Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis","volume":"18","author":"Simpson","year":"2012","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.jtauto.2020.100039_bib98","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nm0598-537a","article-title":"HHV-6 and multiple sclerosis","volume":"4","author":"Fillet","year":"1998","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.jtauto.2020.100039_bib99","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/13550289609146888","article-title":"Detection of Herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction","volume":"2","author":"Sanders","year":"1996","journal-title":"J.\u00a0Neurovirol."},{"issue":"9","key":"10.1016\/j.jtauto.2020.100039_bib100","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1086\/368172","article-title":"Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions","volume":"187","author":"Goodman","year":"2003","journal-title":"JID (J. Infect. Dis.)"},{"issue":"5","key":"10.1016\/j.jtauto.2020.100039_bib101","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/315893","article-title":"Tissue distribution and variant characterization of human herpesvirus (HHV)- 6: increased prevalence of HHV-6A in patients with multiple sclerosis","volume":"182","author":"Akhyani","year":"2000","journal-title":"JID (J. Infect. Dis.)"},{"issue":"2","key":"10.1016\/j.jtauto.2020.100039_bib102","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jmv.10190","article-title":"Human herpesvirus6 andmultiple sclerosis: a study of T cell cross-reactivity to viral and myelin basic protein antigens","volume":"68","author":"Cirone","year":"2002","journal-title":"J.\u00a0Med. Virol."},{"issue":"2","key":"10.1016\/j.jtauto.2020.100039_bib103","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.10425","article-title":"Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis","volume":"53","author":"Tejada-Simon","year":"2003","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.jtauto.2020.100039_bib104","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0092-8674(00)81678-5","article-title":"CD46 is a cellular receptor for human herpesvirus 6","volume":"99","author":"Santoro","year":"1999","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jtauto.2020.100039_bib105","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2741\/4010","article-title":"Cross-reactivity of autoreactive. T cells with MBP and viral antigens in patients with MS","volume":"17","author":"Cheng","year":"2012","journal-title":"Front. Biosci."},{"issue":"12","key":"10.1016\/j.jtauto.2020.100039_bib106","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.4049\/jimmunol.164.12.6091","article-title":"Cutting edge: CD46, a new costimulatory. molecule for T cells, that induces p120(CBL) and LAT. phosphorylation","volume":"164","author":"Astier","year":"2000","journal-title":"J.\u00a0Immunol."},{"issue":"7","key":"10.1016\/j.jtauto.2020.100039_bib107","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients withmultiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"issue":"7","key":"10.1016\/j.jtauto.2020.100039_bib108","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/ni810","article-title":"Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell-induced inflammation","volume":"3","author":"Marie","year":"2002","journal-title":"Nat. Immunol."},{"issue":"6921","key":"10.1016\/j.jtauto.2020.100039_bib109","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature01315","article-title":"Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype","volume":"421","author":"Kemper","year":"2003","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jtauto.2020.100039_bib110","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1172\/JCI29251","article-title":"Alterations in CD46-mediated Tr1 regulatory T cells in patients withmultiple sclerosis","volume":"116","author":"Astier","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"issue":"1\u20132","key":"10.1016\/j.jtauto.2020.100039_bib111","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jneuroim.2008.01.002","article-title":"Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis","volume":"195","author":"Vaknin-Dembinsky","year":"2008","journal-title":"J.\u00a0Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jtauto.2020.100039_bib112","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2249.1999.00917.x","article-title":"Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE)","volume":"116","author":"Kawano","year":"1999","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.jtauto.2020.100039_bib113","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ana.1135","article-title":"Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients withmultiple sclerosis","volume":"50","author":"Soldan","year":"2001","journal-title":"Ann. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jtauto.2020.100039_bib114","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.virusres.2005.01.005","article-title":"Co-purification of soluble membrane cofactor protein (CD46) and human herpesvirus 6 variant A genome in serum from multiple sclerosis patients","volume":"110","author":"Fogdell-Hahn","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.jtauto.2020.100039_bib115","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1386-6532(06)70007-5","article-title":"Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients","volume":"37","author":"Alvarez-Lafuente","year":"2006","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.jtauto.2020.100039_bib116","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40246-015-0029-z","article-title":"Complement regulator CD46: genetic variants and disease associations","volume":"9","author":"Liszewski","year":"2015","journal-title":"Hum. Genom."},{"key":"10.1016\/j.jtauto.2020.100039_bib117","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.3389\/fimmu.2018.02803","article-title":"Induction of proinflammatory multiple sclerosis-associated retrovirus envelope protein by human herpesvirus-6A and CD46 receptor engagement","volume":"9","author":"Charvet","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jtauto.2020.100039_bib118","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0895-4356(98)00030-4","article-title":"The varicella-zoster virus and multiple sclerosis","volume":"51","author":"Ross","year":"1998","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.jtauto.2020.100039_bib119","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1034\/j.1600-0404.2002.1o077.x","article-title":"Varicella, ephemeral breastfeeding and eczema as risk factors for multiple sclerosis in Mexicans","volume":"105","author":"Tarrats","year":"2002","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jtauto.2020.100039_bib120","first-page":"29","article-title":"Herpes zoster and multiple sclerosis","volume":"26","author":"Ross","year":"1999","journal-title":"The Canadian Journal of Neurological Sciences Le journal canadien des sciences neurologiques"},{"key":"10.1016\/j.jtauto.2020.100039_bib121","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archneur.61.4.529","article-title":"Brief presence of varicella\u2013zoster viral DNA in mononuclear cells during relapses of multiple sclerosis","volume":"61","author":"Ordo\u00f1ez","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jtauto.2020.100039_bib122","first-page":"493","article-title":"Varicella\u2013zoster virus at relapses of multiple sclerosis","volume":"254","author":"Sotelo","year":"2007","journal-title":"J.\u00a0Neurol."},{"issue":"3","key":"10.1016\/j.jtauto.2020.100039_bib123","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.34158","article-title":"The high prevalence of the varicella zoster virus in patients with relapsing-remitting multiple sclerosis: a case-control study in the north of Iran","volume":"9","author":"Najafi","year":"2016","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/j.jtauto.2020.100039_bib124","first-page":"5","article-title":"Varicella zoster virus and relapsing remitting multiple sclerosis","author":"Corona","year":"2011","journal-title":"Multiple Sclerosis International"},{"key":"10.1016\/j.jtauto.2020.100039_bib125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00019052-200106000-00015","article-title":"Chlamydia pneumoniae infection of the central nervous system","volume":"14","author":"Yucesan","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jtauto.2020.100039_bib126","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/1531-8249(199907)46:1<6::AID-ANA4>3.0.CO;2-M","article-title":"Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis","volume":"46","author":"Sriram","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jtauto.2020.100039_bib127","series-title":"Chlamydophila Pneumoniae DNA and mRNA Transcript Levels in Peripheral Blood Mononuclear Cells and Cerebrospinal Fluid of Patients with Multiple Sclerosis Neuroscience Research","author":"Fainardi","year":"2008"},{"key":"10.1016\/j.jtauto.2020.100039_bib128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1191\/1352458506ms1291oa","article-title":"Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis","volume":"12","author":"Bagos","year":"2006","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.jtauto.2020.100039_bib129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/156720208783565609","article-title":"Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis","volume":"5","author":"E1","year":"2008","journal-title":"Curr. Neurovascular Res."},{"issue":"3","key":"10.1016\/j.jtauto.2020.100039_bib130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3748\/wjg.v20.i3.613","article-title":"Helicobacter pylori and autoimmune disease: cause or bystander","volume":"20","author":"Smyk","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2020.100039_bib131","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2174\/156652411797536660","article-title":"Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases","volume":"11","author":"Deretzi","year":"2011","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.jtauto.2020.100039_bib132","first-page":"353","article-title":"Relationship between Helicobacter pylori infection and multiple sclerosis","volume":"28","author":"Gavalas","year":"2015","journal-title":"Ann. Gastroenterol."},{"issue":"12","key":"10.1016\/j.jtauto.2020.100039_bib133","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1177\/1352458509348961","article-title":"Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica","volume":"15","author":"Li","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2020.100039_bib134","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000345838","article-title":"Helicobacter pylori infection in neuromyelitis optica and multiple sclerosis","volume":"20","author":"Long","year":"2013","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"10.1016\/j.jtauto.2020.100039_bib135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-07801-9","article-title":"Bogdanos Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis","volume":"7","author":"Efthymiou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2020.100039_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2016.03.037","article-title":"Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis","volume":"620","author":"Yao","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jtauto.2020.100039_bib137","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fmicb.2015.00052","article-title":"Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis","volume":"6","author":"Cook","year":"2015","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.jtauto.2020.100039_bib138","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/jnnp-2014-309495","article-title":"Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females","volume":"86","author":"Pedrini","year":"2015","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.jtauto.2020.100039_bib139","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.msard.2016.03.013","article-title":"Association between Helicobacter pylori infection and multiple sclerosis: a systematic review and meta-analysis","volume":"7","author":"Jaruvongvanich","year":"2016","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.jtauto.2020.100039_bib140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jnnp-2012-302925","article-title":"Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status","volume":"84","author":"Yoshimura","year":"2013","journal-title":"Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jtauto.2020.100039_bib141","doi-asserted-by":"crossref","first-page":"22401","DOI":"10.1038\/srep22401","article-title":"Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients","volume":"6","author":"Mameli","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2020.100039_bib142","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2014.02.013","article-title":"bEpstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients","volume":"270","author":"Mameli","year":"2014","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jtauto.2020.100039_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018482","article-title":"Association of Mycobacterium avium subsp. paratuberculosis with multiple sclerosis in Sardinian patients","volume":"6","author":"Cossu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jtauto.2020.100039_bib144","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/1352458511433430","article-title":"Are Mycobacterium avium subsp. paratuberculosis and Epstein-Barr virus triggers of multiple sclerosis in Sardinia?","volume":"18","author":"Cossu","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2020.100039_bib145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2217\/fmb.12.135","article-title":"A\u00a0Sardinian map for multiple sclerosis","volume":"8","author":"Cossu","year":"2013","journal-title":"Future Microbiol."},{"key":"10.1016\/j.jtauto.2020.100039_bib146","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1177\/1352458514557304","article-title":"Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients","volume":"21","author":"Cossu","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2020.100039_bib147","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fneur.2017.00216","article-title":"Conflicting role of Mycobacterium species in multiple sclerosis","volume":"8","author":"Cossu","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jtauto.2020.100039_bib148","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1038\/s41598-017-03370-z","article-title":"Altered humoral immunity to mycobacterial antigens in Japanese patients affected by inflammatory demyelinating diseases of the central nervous system","volume":"7","author":"Cossu","year":"2017","journal-title":"v Sci. Rep."},{"key":"10.1016\/j.jtauto.2020.100039_bib149","first-page":"S6","article-title":"Mycoplasma pneumonia seroposivity in Iranian patients with relapsingremitting multiple sclerosis: a randomized case-control study","volume":"62","author":"Bahar","year":"2012","journal-title":"J.\u00a0Pakistan Med. Assoc."},{"key":"10.1016\/j.jtauto.2020.100039_bib150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1756285613488434","article-title":"Sex and gender issues in multiple sclerosis","volume":"6","author":"Harbo","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jtauto.2020.100039_bib151","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1352458507082149","article-title":"PCR for bacterial 16S ribosomal DNA in multiple sclerosis cerebrospinal fluid","volume":"14","author":"Lindsey","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jtauto.2020.100039_bib152","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vetmic.2008.02.015","article-title":"Binding of epsilon-toxin from Clostridium perfringens in the nervous system","volume":"131","author":"Dorca-Ar\u00e9valo","year":"2008","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jtauto.2020.100039_bib153","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/WNO.0b013e318238937f","article-title":"Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection","volume":"31","author":"Sakai","year":"2011","journal-title":"J.\u00a0Neuro Ophthalmol."},{"key":"10.1016\/j.jtauto.2020.100039_bib154","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.jtauto.2020.100039_bib155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/19490976.2017.1349041","article-title":"Gut microbiome in multiple sclerosis: the players involved and the roles they play","volume":"8","author":"Shahi","year":"2017","journal-title":"Gut Microb."},{"key":"10.1016\/j.jtauto.2020.100039_bib156","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4049\/jimmunol.1601438","article-title":"Influence of the gut microbiome on autoimmunity in the central nervous system","volume":"198","author":"Colpitts","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jtauto.2020.100039_bib157","doi-asserted-by":"crossref","first-page":"53","DOI":"10.21037\/atm.2017.01.63","article-title":"The multiple sclerosis microbiome?","volume":"5","author":"Tremlett","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jtauto.2020.100039_bib158","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/365642a0","article-title":"Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen","volume":"365","author":"Brocke","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jtauto.2020.100039_bib159","first-page":"564","article-title":"Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis","volume":"10","author":"Sewell","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jtauto.2020.100039_bib160","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.4049\/jimmunol.181.9.6201","article-title":"Mycobacterium bovis bacille Calmette-Gu\u00e9rin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFNgamma-independent manner","volume":"181","author":"Lee","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jtauto.2020.100039_bib161","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jns.2014.09.023","article-title":"Evaluation of the humoral response against mycobacterial peptides, homologous to MOG35 55, in multiple sclerosis patients","volume":"347","author":"Cossu","year":"2014","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.jtauto.2020.100039_bib162","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/01.wnl.0000438216.93319.ab","article-title":"Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS","volume":"82","author":"Ristori","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2020.100039_bib163","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2017.00407","article-title":"Immune responses to Bacillus Calmette-Gu\u00e9rin vaccination: why do they fail to protect against Mycobacterium tuberculosis?","volume":"8","author":"Moliva","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2020.100039_bib164","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1535370217743766","article-title":"Gut reactions: how the blood-brain barrier connects the microbiome and the brain","volume":"243","author":"Logsdon","year":"2018","journal-title":"Exp. Biol. Med."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258990902030006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258990902030006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:35:08Z","timestamp":1762904108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258990902030006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":164,"alternative-id":["S258990902030006X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2020.100039","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-mediated genesis of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2020.100039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100039"}}